{"id":"https://openalex.org/W7010349979","doi":null,"title":"Identification of Patient Characteristics Affecting Outcomes in Mono-Immunotherapy Versus Combination Treatment in Stage IV NSCLC","display_name":"Identification of Patient Characteristics Affecting Outcomes in Mono-Immunotherapy Versus Combination Treatment in Stage IV NSCLC","publication_year":2025,"publication_date":"2025-03-22","ids":{"openalex":"https://openalex.org/W7010349979"},"language":"en","primary_location":{"id":"pmh:oai:scholar.uwindsor.ca:we-spark-conference-1149","doi":null,"is_oa":false,"landing_page_url":"https://scholar.uwindsor.ca/we-spark-conference/2025/postersessions/117","pdf_url":null,"source":{"id":"https://openalex.org/S4306400430","display_name":"Scholarship at UWindsor (University of Windsor)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I74413500","host_organization_name":"University of Windsor","host_organization_lineage":["https://openalex.org/I74413500"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"WE-SPARK Health Research Conference","raw_type":"text"},"volume":null,"type":"conference-paper","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Khan, Almas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khan, Almas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Mung, Alexander","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mung, Alexander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Kulkarni, Swati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kulkarni, Swati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.61471442,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.3822999894618988,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.3822999894618988,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3707999885082245,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.16300000250339508,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stage-iv-non-small-cell-lung-cancer","display_name":"stage IV non-small cell lung cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.8920000195503235},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.7870000004768372},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5929999947547913},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7689999938011169},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8050000071525574},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.6159999966621399},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.9340000152587891},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.6909999847412109},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.5189999938011169},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9021000266075134},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7143999934196472},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6610000133514404},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6577000021934509},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5831000208854675},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5087000131607056},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49639999866485596},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.47189998626708984},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4239000082015991},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4059000015258789},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.40459999442100525},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.38670000433921814},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.37950000166893005},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.3698999881744385},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.3467000126838684},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.32850000262260437},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.32190001010894775},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.31060001254081726},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.3077000081539154},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.28529998660087585},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.27549999952316284},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.26899999380111694},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.2531000077724457}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:scholar.uwindsor.ca:we-spark-conference-1149","doi":null,"is_oa":false,"landing_page_url":"https://scholar.uwindsor.ca/we-spark-conference/2025/postersessions/117","pdf_url":null,"source":{"id":"https://openalex.org/S4306400430","display_name":"Scholarship at UWindsor (University of Windsor)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I74413500","host_organization_name":"University of Windsor","host_organization_lineage":["https://openalex.org/I74413500"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"WE-SPARK Health Research Conference","raw_type":"text"},{"id":"pmh:oai:uwindsor.scholaris.ca:20.500.14776/15752","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/20.500.14776/15752","pdf_url":null,"source":{"id":"https://openalex.org/S4306400430","display_name":"Scholarship at UWindsor (University of Windsor)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I74413500","host_organization_name":"University of Windsor","host_organization_lineage":["https://openalex.org/I74413500"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Conference presentation"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.41523370146751404,"id":"https://metadata.un.org/sdg/1","display_name":"No poverty"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Lung":[0],"cancer":[1,7],"remains":[2],"the":[3,9,45,93],"most":[4],"commonly":[5],"diagnosed":[6],"and":[8,67,91,173,176,192,205],"leading":[10],"cause":[11],"of":[12,29,75,95],"cancer-related":[13],"deaths":[14],"worldwide,":[15],"primarily":[16],"due":[17],"to":[18,84,132,201],"late-stage":[19],"diagnoses.":[20],"Non-small":[21],"cell":[22],"lung":[23],"carcinoma":[24],"(NSCLC)":[25],"accounts":[26],"for":[27,212],"85%":[28],"cases,":[30],"with":[31,70,104,110,161,195],"historically":[32],"poor":[33,113],"survival":[34],"rates":[35],"in":[36,56,159,185],"Stage":[37,144,213],"IV":[38,145,214],"disease.":[39],"While":[40],"platinum-based":[41],"chemotherapy":[42,162],"has":[43,53],"been":[44],"standard":[46],"first-line":[47],"treatment,":[48],"immunotherapy":[49,120,156],"targeting":[50],"PD-1/PD-L1":[51],"pathways":[52],"shown":[54],"promise":[55],"enhancing":[57],"immune":[58],"responses":[59],"against":[60],"tumors.":[61],"Clinical":[62],"trials":[63],"support":[64],"both":[65],"mono-immunotherapy":[66,96],"combination":[68,98,133,160],"therapy":[69],"chemotherapy,":[71],"but":[72],"direct":[73],"comparisons":[74],"their":[76,193],"relative":[77],"efficacies":[78],"remain":[79],"limited.":[80],"This":[81],"study":[82,199],"aims":[83],"assess":[85],"patient-specific":[86],"factors":[87],"influencing":[88],"treatment":[89,203],"outcomes":[90,191],"compare":[92],"efficacy":[94],"versus":[97],"therapy.":[99,134],"We":[100],"hypothesize":[101],"that":[102],"patients":[103,125,147],"high":[105],"toxicity":[106],"risk\u2014such":[107],"as":[108],"those":[109],"advanced":[111],"age,":[112],"performance":[114],"status,":[115],"or":[116,126,158],"comorbidities\u2014will":[117],"benefit":[118],"from":[119,148],"alone,":[121],"while":[122],"younger,":[123],"healthier":[124],"immunocompromised":[127],"individuals":[128],"may":[129],"respond":[130],"better":[131],"Using":[135],"a":[136],"prospective":[137],"cohort":[138],"design,":[139],"we":[140],"will":[141,163,181],"recruit":[142],"80-100":[143],"NSCLC":[146,215],"Windsor":[149],"Regional":[150],"Cancer":[151],"Centre.":[152],"Patients":[153],"receiving":[154],"either":[155],"alone":[157],"be":[164],"analyzed":[165],"based":[166],"on":[167],"survival,":[168],"response":[169],"rates,":[170],"adverse":[171],"events,":[172],"key":[174],"demographic":[175],"clinical":[177,190],"factors.":[178],"Statistical":[179],"analyses":[180],"determine":[182],"significant":[183],"differences":[184],"outcomes.":[186],"By":[187],"evaluating":[188],"real-world":[189],"association":[194],"patient":[196],"characteristics,":[197],"this":[198],"seeks":[200],"refine":[202],"guidelines":[204],"promote":[206],"personalized":[207],"therapy,":[208],"ultimately":[209],"improving":[210],"prognoses":[211],"patients.":[216]},"counts_by_year":[],"updated_date":"2026-09-02T18:50:13.731487","created_date":"2025-10-10T00:00:00"}